Gilder Gagnon Howe & CO LLC 10x Genomics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

  • $7.59 Billion
  • Q2 2024

A detailed history of Gilder Gagnon Howe & CO LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 24,394 shares of TXG stock, worth $386,888. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,394
Previous 504,174 95.16%
Holding current value
$386,888
Previous $18.9 Million 97.49%
% of portfolio
0.01%
Previous 0.25%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$19.45 - $37.37 $9.33 Million - $17.9 Million
-479,780 Reduced 95.16%
24,394 $474,000
Q1 2024

May 15, 2024
BUY
$36.08 - $54.3 $61,444 - $92,472
1,703 Added 0.34%
504,174 $18.9 Million
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $114,972 - $192,792
3,350 Added 0.67%
502,471 $28.1 Million
Q3 2023

Nov 14, 2023
BUY
$40.86 - $62.98 $19.4 Million - $29.8 Million
473,845 Added 1874.68%
499,121 $20.6 Million
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $487,483 - $561,715
9,566 Added 60.89%
25,276 $1.41 Million
Q1 2023

May 15, 2023
BUY
$35.33 - $55.79 $197,424 - $311,754
5,588 Added 55.21%
15,710 $876,000
Q4 2022

Feb 14, 2023
SELL
$24.4 - $41.3 $355,752 - $602,154
-14,580 Reduced 59.02%
10,122 $368,000
Q3 2022

Nov 14, 2022
SELL
$28.48 - $52.59 $15.5 Million - $28.5 Million
-542,785 Reduced 95.65%
24,702 $704,000
Q2 2022

Aug 15, 2022
SELL
$36.95 - $82.41 $6.51 Million - $14.5 Million
-176,294 Reduced 23.7%
567,487 $25.7 Million
Q1 2022

May 16, 2022
SELL
$55.7 - $145.79 $1.26 Million - $3.3 Million
-22,647 Reduced 2.95%
743,781 $56.6 Million
Q4 2021

Feb 14, 2022
SELL
$135.05 - $182.59 $1.53 Million - $2.07 Million
-11,319 Reduced 1.46%
766,428 $114 Million
Q3 2021

Nov 15, 2021
BUY
$145.58 - $192.14 $134,224 - $177,153
922 Added 0.12%
777,747 $113 Million
Q2 2021

Aug 16, 2021
SELL
$134.22 - $202.37 $645,598 - $973,399
-4,810 Reduced 0.62%
776,825 $152 Million
Q1 2021

May 17, 2021
SELL
$140.25 - $196.86 $2.11 Million - $2.96 Million
-15,020 Reduced 1.89%
781,635 $141 Million
Q4 2020

Feb 16, 2021
BUY
$126.47 - $163.7 $13.7 Million - $17.7 Million
108,044 Added 15.69%
796,655 $113 Million
Q3 2020

Nov 16, 2020
BUY
$87.44 - $125.0 $14.8 Million - $21.2 Million
169,443 Added 32.64%
688,611 $85.9 Million
Q2 2020

Aug 14, 2020
BUY
$58.39 - $89.31 $30.3 Million - $46.4 Million
519,168 New
519,168 $46.4 Million

Others Institutions Holding TXG

# of Institutions
286
Shares Held
95.8M
Call Options Held
162K
Put Options Held
107K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email